Simplex Trading’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$770K Buy
31,200
+23,200
+290% +$406K ﹤0.01% 2764
2025
Q4
$135K Buy
8,000
+200
+3% +$3.52K ﹤0.01% 4661
2025
Q3
$169K Sell
7,800
-31,400
-80% -$521K ﹤0.01% 5138
2025
Q2
$558K Buy
39,200
+34,400
+717% +$544K ﹤0.01% 3393
2025
Q1
$62K Sell
4,800
-1,000
-17% -$15.1K ﹤0.01% 5557
2024
Q4
$77K Sell
5,800
-3,700
-39% -$37.5K ﹤0.01% 5422
2024
Q3
$57K Buy
9,500
+700
+8% +$2.96K ﹤0.01% 5768
2024
Q2
$28K Buy
8,800
+4,200
+91% +$14.7K ﹤0.01% 6602
2024
Q1
$17K Sell
4,600
-100
-2% -$437 ﹤0.01% 7213
2023
Q4
$20K Sell
4,700
-6,500
-58% -$26.1K ﹤0.01% 6928
2023
Q3
$46K Sell
11,200
-3,800
-25% -$14.7K ﹤0.01% 5884
2023
Q2
$52K Buy
15,000
+6,100
+69% +$22.4K ﹤0.01% 5806
2023
Q1
$34K Sell
8,900
-41,900
-82% -$153K ﹤0.01% 6363
2022
Q4
$143K Sell
50,800
-1,400
-3% -$3.76K ﹤0.01% 4650
2022
Q3
$109K Sell
52,200
-42,900
-45% -$107K ﹤0.01% 5397
2022
Q2
$249K Buy
95,100
+15,400
+19% +$51.7K ﹤0.01% 4340
2022
Q1
$347K Buy
79,700
+58,700
+280% +$231K ﹤0.01% 4332
2021
Q4
$90K Buy
21,000
+11,000
+110% +$52.6K ﹤0.01% 6426
2021
Q3
$62K Hold
10,000
﹤0.01% 7260
2021
Q2
$61K Buy
+10,000
New +$74.1K ﹤0.01% 7402

Other funds holding ETON

Simplex Trading's ETON Position: Q2 2025 in Review

Simplex Trading sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 4,472 shares — an estimated $70.7K sold.

Simplex Trading first reported a position in ETON in Q1 2021 and held it in 6 quarters. The position peaked at $484K in Q4 2024. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • Simplex Trading reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 4,472 Eton Pharmaceutcials shares in Q2 2025, an estimated $70.7K.
  • Simplex Trading first reported a position in Eton Pharmaceutcials in Q1 2021 and held it in 6 quarters.
  • Simplex Trading's Eton Pharmaceutcials position peaked at $484K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.